NSE · AI Signal & Stock Analysis · Neutral
As of Aug 20 2026, 5:48 AM, AkshayaAI's signal for MOREPENLAB is Neutral → (extreme move); technical trend down-trend; trading at ₹51.90 (-2.44% today); neutral (RSI 39).
Data as of Aug 20 2026, 5:48 AM. Informational analytics only — not investment advice.
| AI signal | Neutral → · Extreme move |
|---|---|
| Technical trend | Down-trend (since 2026-07-20) |
| Price | ₹51.90 |
| Change today | -2.44% |
| RSI (14) | 38.90 |
| Relative volume | 0.32 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | ₹5,286 Cr |
| P/E | 37.68 |
| Cap category | Mid Cap |
| 52-week high | -17.2% away |
| 52-week low | +54.1% above |
| Delivery volume | — |
| Sector | Drug Manufacturers - Specialty & Generic |
As of Aug 20 2026, 5:48 AM, AkshayaAI's signal for MOREPENLAB (Morepen Laboratories Limited) is Neutral with a extreme move, and its technical trend is down-trend. The composite score and full factor breakdown are available to signed-in members.
MOREPENLAB's RSI is neutral (RSI 39). A reading above 70 is typically overbought and below 30 oversold.
MOREPENLAB is trading about 17% below its 52-week high and 54% above its 52-week low as of Aug 20 2026, 5:48 AM.
MOREPENLAB's market capitalisation is ₹5,286 Cr as of Aug 20 2026, 5:48 AM.
MOREPENLAB is classified under Drug Manufacturers - Specialty & Generic in AkshayaAI's taxonomy.
AkshayaAI refreshes its signals daily. The figures on this page are timestamped as of the latest run shown above.
No. AkshayaAI provides informational, AI-generated analytics for MOREPENLAB — not personalised investment advice. Always do your own research.
AARTIPHARM · ABBOTINDIA · AJANTPHARM · AKUMS · ALIVUS · ALKEM
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 20 2026, 5:48 AM and may not reflect real-time prices. Always do your own research. How these signals work →
Instant, data-backed answers — free to try.